Calreticulin mutation does not modify the IPSET score for predicting the risk of thrombosis among 1150 patients with essential thrombocythemia
-
- Guido Finazzi
- Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
-
- Alessandra Carobbio
- Research Foundation, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
-
- Paola Guglielmelli
- Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
-
- Chiara Cavalloni
- Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
-
- Silvia Salmoiraghi
- Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
-
- Alessandro M. Vannucchi
- Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
-
- Mario Cazzola
- Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
-
- Francesco Passamonti
- Division of Hematology, Department of Medicine, Ospedale di Circolo e Fondazione Macchi, Varese, Italy
-
- Alessandro Rambaldi
- Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
-
- Tiziano Barbui
- Research Foundation, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
収録刊行物
-
- Blood
-
Blood 124 (16), 2611-2612, 2014-10-16
American Society of Hematology